ATLANTIS: A Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line

Anna F. Farago, Benjamin J. Drapkin, Jose Antonio Lopez-Vilarino De Ramos, Carlos M. Galmarini, Rafael Núñez, Carmen Kahatt, Luis Paz-Ares

Research output: Contribution to journalArticle

11 Scopus citations

Fingerprint Dive into the research topics of 'ATLANTIS: A Phase III study of lurbinectedin/doxorubicin versus topotecan or cyclophosphamide/doxorubicin/vincristine in patients with small-cell lung cancer who have failed one prior platinum-containing line'. Together they form a unique fingerprint.

Medicine & Life Sciences